|
Market Closed -
London S.E.
12:07:39 2026-04-16 EDT
|
5-day change | 1st Jan Change | ||
| 268.40 SEK | +25.07% |
|
+19.82% | +43.02% |
| 10-13 | Nordea reiterates buy on Bonesupport, sees underestimated growth potential | FW |
| 10-12 | Lancelot Sverige rose 2.0 percent in September, positive study results for Bonesupport | FW |
Company Valuation: Bonesupport Holding AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,823 | 5,191 | 12,243 | 25,453 | 12,382 | 16,594 | - | - |
| Change | - | 83.87% | 135.87% | 107.89% | -51.36% | 34.02% | - | - |
| Enterprise Value (EV) 1 | 2,638 | 4,989 | 12,076 | 25,226 | 12,015 | 16,051 | 15,744 | 15,251 |
| Change | - | 89.13% | 142.03% | 108.9% | -52.37% | 33.59% | -1.91% | -3.13% |
| P/E | -32.8x | -75.9x | 50.3x | 192x | 88.3x | 52.6x | 33x | 24.3x |
| PBR | 10.6x | 19.3x | 22.6x | 35x | 14.5x | 14.8x | 10.6x | 7.49x |
| PEG | - | 3.6x | -0x | -4.2x | 14.79x | 0x | 0.6x | 0.7x |
| Capitalization / Revenue | 13.3x | 15.8x | 20.7x | 28.3x | 10.5x | 11.1x | 8.31x | 6.58x |
| EV / Revenue | 12.4x | 15.2x | 20.4x | 28.1x | 10.2x | 10.7x | 7.88x | 6.05x |
| EV / EBITDA | -32.7x | -77.3x | 867x | 146x | 50.2x | 37.2x | 23.4x | 16.8x |
| EV / EBIT | -32.7x | -77.3x | 867x | 152x | 51.9x | 39.3x | 24.2x | 16.4x |
| EV / FCF | -30.4x | -99.4x | -633x | 424x | 54.9x | 62.5x | 42.8x | 26.4x |
| FCF Yield | -3.29% | -1.01% | -0.16% | 0.24% | 1.82% | 1.6% | 2.34% | 3.79% |
| Dividend per Share 2 | - | - | - | - | - | 1.465 | 2.185 | 3.02 |
| Rate of return | - | - | - | - | - | 0.58% | 0.86% | 1.19% |
| EPS 2 | -1.34 | -1.06 | 3.74 | 2.01 | 2.13 | 4.818 | 7.672 | 10.43 |
| Distribution rate | - | - | - | - | - | 30.4% | 28.5% | 29% |
| Net sales 1 | 212.9 | 328.8 | 591.1 | 898.7 | 1,175 | 1,498 | 1,997 | 2,522 |
| EBITDA 1 | -80.67 | -64.54 | 13.93 | 173.4 | 239.4 | 431.9 | 673.9 | 910.1 |
| EBIT 1 | -80.67 | -64.54 | 13.93 | 166.1 | 231.7 | 408.8 | 650.1 | 928.4 |
| Net income 1 | -85.53 | -68.17 | 245 | 133.8 | 142.2 | 319.8 | 508.3 | 691.9 |
| Net Debt 1 | -185 | -201.3 | -167.4 | -227 | -366.3 | -543.3 | -849.9 | -1,343 |
| Reference price 2 | 44.00 | 80.45 | 188.20 | 386.80 | 188.00 | 253.40 | 253.40 | 253.40 |
| Nbr of stocks (in thousands) | 64,162 | 64,521 | 65,056 | 65,805 | 65,859 | 65,486 | - | - |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | 2/25/25 | 2/24/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.19x | 12.03x | 25.3x | 0.59% | 1,040B | |
| 36.75x | 6.12x | 17.02x | 2.15% | 599B | |
| 34.92x | 8.07x | 16.64x | 2.53% | 485B | |
| 109.67x | 5.8x | 24.85x | 2.4% | 350B | |
| 19.42x | 4.74x | 11.78x | 2.78% | 345B | |
| 20.05x | 5.27x | 12.97x | 3.02% | 272B | |
| 20.63x | 4.17x | 11.97x | 2.12% | 244B | |
| 26.21x | 6.79x | 12.15x | 2.44% | 223B | |
| -43.22x | 6.62x | 25.76x | 2.23% | 183B | |
| Average | 28.63x | 6.62x | 17.61x | 2.25% | 415.87B | |
| Weighted average by Cap. | 33.93x | 7.73x | 19.04x | 1.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BONEX Stock
- 0RQO Stock
- Valuation Bonesupport Holding AB
Select your edition
All financial news and data tailored to specific country editions
